TrialAnnals of the rheumatic diseases2004

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.

S B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.